Martinez-Sanchez, Julia
Palomo, Marta
Torramade-Moix, Sergi
Moreno-Castaño, Ana Belen
Rovira, Montserrat
Gutiérrez-García, Gonzalo http://orcid.org/0000-0003-4084-8279
Fernández-Avilés, Francesc
Escolar, Gines
Penack, Olaf
Rosiñol, Laura
Carreras, Enric
Diaz-Ricart, Maribel http://orcid.org/0000-0003-1122-0052
Funding for this research was provided by:
Jazz Pharmaceuticals (IST-16-10355, IST-16-10355, IST-16-10355, IST-16-10355)
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (PIE15/00027, DTS16/00133, PI19/00888)
Generalitat de Catalunya (2017-SGR675)
Article History
Received: 18 March 2020
Revised: 30 April 2020
Accepted: 4 May 2020
First Online: 13 May 2020
Compliance with ethical standards
:
: Research partially supported by Jazz Pharmaceuticals plc/Gentium Inc. MP received speaker’s fees from Jazz Pharmaceuticals. GG-G received a grant from Pfizer and Gilead. GE, OP, EC, and MD-R received research funding and speaker’s fees from Jazz Pharmaceuticals. LR received honoraria from Janssen, Celgene, Amgen, and Takeda. The other authors declare that they have no conflict of interest.